SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA (1282)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTE	COMPLEXITY
Anti-proteinase-3 (Pr-3) antibodies (K010287 | K010287)	HIGH Effective Date: 2001-03-28

Other General Immunology Devices:

Medical Device	Complexity
Beckman Coulter AU600 Chemistry Analyzer	View Complexity
IMMCO Diagnostics Autoantibody Test System	View Complexity
Euroimmun Anti-nRNP/Sm ELISA (IgG)	View Complexity
Granbio Inc. EBNA Anti-complement IFA	View Complexity
BECTON DICKINSON FACS CANTO	View Complexity
ROCHE DIAGNOSTICS COBAS FARA II	View Complexity
Beckman Coulter Unicel DxC 600i Synchron Access Clinical System	View Complexity
Beckman Paragon SPE-II Electrophoresis Kit	View Complexity
ACON Mononucleosis Rapid Test Device	View Complexity
Olympus Au 5200	View Complexity